Therefore, further investigation are warranted in regard to the mechanisms of NPC pyroptosis mediated by NLRP3 inflammasome, in order to uncover potential therapeutic targets for IDD treatment. This evidence concerns the gene NLRP3 and nasopharyngeal carcinoma.